Dynavax Technologies Corp (DVAX)
11.78
+0.44
(+3.88%)
USD |
NASDAQ |
Apr 19, 16:00
11.77
-0.01
(-0.08%)
After-Hours: 20:00
Dynavax Technologies Total Liabilities (Quarterly): 375.02M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 375.02M |
September 30, 2023 | 368.02M |
June 30, 2023 | 359.23M |
March 31, 2023 | 406.19M |
December 31, 2022 | 404.84M |
September 30, 2022 | 498.76M |
June 30, 2022 | 600.20M |
March 31, 2022 | 721.49M |
December 31, 2021 | 816.87M |
September 30, 2021 | 852.14M |
June 30, 2021 | 564.53M |
March 31, 2021 | 390.36M |
December 31, 2020 | 294.58M |
September 30, 2020 | 284.11M |
June 30, 2020 | 271.02M |
March 31, 2020 | 247.43M |
December 31, 2019 | 270.78M |
September 30, 2019 | 261.86M |
June 30, 2019 | 256.49M |
March 31, 2019 | 253.44M |
December 31, 2018 | 147.82M |
September 30, 2018 | 139.38M |
June 30, 2018 | 132.55M |
March 31, 2018 | 129.45M |
December 31, 2017 | 19.24M |
Date | Value |
---|---|
September 30, 2017 | 13.39M |
June 30, 2017 | 11.44M |
March 31, 2017 | 12.74M |
December 31, 2016 | 20.48M |
September 30, 2016 | 31.03M |
June 30, 2016 | 28.84M |
March 31, 2016 | 25.21M |
December 31, 2015 | 29.55M |
September 30, 2015 | 27.72M |
June 30, 2015 | 34.97M |
March 31, 2015 | 37.10M |
December 31, 2014 | 37.81M |
September 30, 2014 | 25.32M |
June 30, 2014 | 22.80M |
March 31, 2014 | 19.73M |
December 31, 2013 | 18.33M |
September 30, 2013 | 19.30M |
June 30, 2013 | 19.35M |
March 31, 2013 | 21.69M |
December 31, 2012 | 24.93M |
September 30, 2012 | 34.76M |
June 30, 2012 | 31.19M |
March 31, 2012 | 32.30M |
December 31, 2011 | 34.22M |
September 30, 2011 | 28.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
247.43M
Minimum
Mar 2020
852.14M
Maximum
Sep 2021
433.89M
Average
375.02M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
Supernus Pharmaceuticals Inc | 356.16M |
Ligand Pharmaceuticals Inc | 86.30M |
Pacira BioSciences Inc | 704.26M |
Esperion Therapeutics Inc | 660.79M |
PetIQ Inc | 645.23M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 997.10M |
Shareholders Equity (Quarterly) | 622.07M |
Debt to Equity Ratio | 0.358 |
Current Ratio | 13.81 |
Net Debt Paydown Yield | -0.02% |